Posted by Bruce G. Haffty, MD, FASTRO
President, ASTRO
We are thrilled to have as our Monday keynote speaker, Hedvig Hricak, MD, PhD, the chair of the Department of Radiology at Memorial Sloan Kettering Cancer Center. Dr. Hricak is renowned internationally for her extensive research and clinical expertise in genitourinary and gynecologic imaging, as well as for her pioneering work in the development of modern multimodality techniques for visualizing the structure and function of male and female genitourinary cancers.
The theme of this year’s meeting is "Targeting Cancer through Technology and Biology". Given her expertise in oncologic imaging, Dr. Hricak is ideally suited as a speaker for this meeting. Her clinical and research efforts in moving forward the field of oncologic and molecular imaging clearly fit the meeting theme from both a biologic and technologic perspective. Her focus on molecular imaging will bring the latest developments in this rapidly evolving and exciting field to our membership.
Dr. Hricak is a board-certified radiologist with expertise in cross-sectional anatomic and molecular imaging, and she is actively involved in clinical practice and research. Her research focuses on the evidence-based use of imaging in cancer management, and she helped develop the use of MRI for gynecologic cancers and the application of MRI and MR spectroscopy for prostate cancer.
At MSKCC, Dr. Hricak is co-director of a program, funded by the National Cancer Institute (NCI), that trains young scientists and physicians on oncologic molecular imaging. The goal of this program is to move toward the rapid development of molecular imaging as a tool to help in future research, as well as to aid in the movement toward individualized clinical care in oncology. Dr. Hricak is also a co-principal investigator on the training section of the National Institutes of Health-funded U54 grant, “The CCNY/MSKCC Partnership for Research, Training and Outreach.” This program aims to recruit and train students, particularly minority students, to develop their interest in cancer research through enhanced education and imaging training, mentorship and support.
Throughout her distinguished career, Dr. Hricak has held a number of important posts and received numerous accolades from around the world. She is a member of the Institute of Medicine, and she served on the Scientific Advisory Board of the NCI and the Advisory Council of the National Institute of Biomedical Imaging and Bioengineering. She also served on the Nuclear Radiation Studies Board of the National Academy of Sciences (NAS) and chaired the NAS Committee on the State of the Science of Nuclear Medicine. Dr. Hricak has published over 380 peer-reviewed original research articles and more than 300 review articles, editorials and book chapters, along with 18 books.
When asked about her career path, Dr. Hricak says: “I am a strong believer that medicine knows no borders, and throughout my career, I have done my best to promote international collaboration in medicine, particularly with respect to education and research.” This focus has led to her receiving honorary membership or fellows designation at twelve radiological societies around the world, among other honors. View an interview with Dr. Hricak here.
ASTRO is honored that she will address our 56th Annual Meeting on Monday, September 15, 2014, 9:15 a.m. – 10:15 a.m. at Moscone Center in San Francisco. More information on the 2014 Annual Meeting is available here.
President, ASTRO
We are thrilled to have as our Monday keynote speaker, Hedvig Hricak, MD, PhD, the chair of the Department of Radiology at Memorial Sloan Kettering Cancer Center. Dr. Hricak is renowned internationally for her extensive research and clinical expertise in genitourinary and gynecologic imaging, as well as for her pioneering work in the development of modern multimodality techniques for visualizing the structure and function of male and female genitourinary cancers.
The theme of this year’s meeting is "Targeting Cancer through Technology and Biology". Given her expertise in oncologic imaging, Dr. Hricak is ideally suited as a speaker for this meeting. Her clinical and research efforts in moving forward the field of oncologic and molecular imaging clearly fit the meeting theme from both a biologic and technologic perspective. Her focus on molecular imaging will bring the latest developments in this rapidly evolving and exciting field to our membership.
Dr. Hricak is a board-certified radiologist with expertise in cross-sectional anatomic and molecular imaging, and she is actively involved in clinical practice and research. Her research focuses on the evidence-based use of imaging in cancer management, and she helped develop the use of MRI for gynecologic cancers and the application of MRI and MR spectroscopy for prostate cancer.
At MSKCC, Dr. Hricak is co-director of a program, funded by the National Cancer Institute (NCI), that trains young scientists and physicians on oncologic molecular imaging. The goal of this program is to move toward the rapid development of molecular imaging as a tool to help in future research, as well as to aid in the movement toward individualized clinical care in oncology. Dr. Hricak is also a co-principal investigator on the training section of the National Institutes of Health-funded U54 grant, “The CCNY/MSKCC Partnership for Research, Training and Outreach.” This program aims to recruit and train students, particularly minority students, to develop their interest in cancer research through enhanced education and imaging training, mentorship and support.
Throughout her distinguished career, Dr. Hricak has held a number of important posts and received numerous accolades from around the world. She is a member of the Institute of Medicine, and she served on the Scientific Advisory Board of the NCI and the Advisory Council of the National Institute of Biomedical Imaging and Bioengineering. She also served on the Nuclear Radiation Studies Board of the National Academy of Sciences (NAS) and chaired the NAS Committee on the State of the Science of Nuclear Medicine. Dr. Hricak has published over 380 peer-reviewed original research articles and more than 300 review articles, editorials and book chapters, along with 18 books.
When asked about her career path, Dr. Hricak says: “I am a strong believer that medicine knows no borders, and throughout my career, I have done my best to promote international collaboration in medicine, particularly with respect to education and research.” This focus has led to her receiving honorary membership or fellows designation at twelve radiological societies around the world, among other honors. View an interview with Dr. Hricak here.
ASTRO is honored that she will address our 56th Annual Meeting on Monday, September 15, 2014, 9:15 a.m. – 10:15 a.m. at Moscone Center in San Francisco. More information on the 2014 Annual Meeting is available here.